3D structures of hypoxia-inducible factor: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) New page: ==3D structures of hypoxia-inducible factor== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *HIF-1α; Human domai... |
Michal Harel (talk | contribs) No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 20: | Line 20: | ||
**[[4lpz]] – hARNT C-terminal PAS + coactivator<br /> | **[[4lpz]] – hARNT C-terminal PAS + coactivator<br /> | ||
**[[4gs9]] – hARNT C-terminal PAS (mutant) + HIF-2 peptide <br /> | **[[4gs9]] – hARNT C-terminal PAS (mutant) + HIF-2 peptide <br /> | ||
**[[5tbm]] – hARNT C-terminal PAS + EPAS-1<br /> | |||
**[[5v0l]] – hARNT 70-345 + mAHR + DNA<br /> | |||
**[[4zp4]], [[4zpk]] – mARNT + mHIF-2 - mouse<br /> | **[[4zp4]], [[4zpk]] – mARNT + mHIF-2 - mouse<br /> | ||
**[[7w80]] – mARNT + mHIF-2 + drug<br /> | |||
**[[5nj8]] – mARNT 85-345 + AHR + DNA<br /> | |||
**[[7vni]] – mARNT 85-345 + DmAHR <br /> | |||
**[[7v7l]], [[7v7w]] – mARNT + mHIF-3 <br /> | |||
**[[5sy5]] – mARNT + NPAS1<br /> | |||
**[[5sy7]] – mARNT + NPAS3 + DNA <br /> | |||
**[[7xhv]], [[7xi4]] – mARNT + NPAS4 + DNA <br /> | |||
*HIF-2α or endothelial PAS domain-containing protein | *HIF-2α or endothelial PAS domain-containing protein | ||
Line 34: | Line 43: | ||
**[[4zqd]], [[6e3t]] – mHIF-2 + ARNT + inhibitor<br /> | **[[4zqd]], [[6e3t]] – mHIF-2 + ARNT + inhibitor<br /> | ||
**[[6e3u]] – mHIF-2 (mutant) + ARNT + agonist<br /> | **[[6e3u]] – mHIF-2 (mutant) + ARNT + agonist<br /> | ||
*HIF-3 | |||
**[[4wn5]] – hHIF-3 C-terminal PAS-B <br /> | |||
}} | }} | ||
[[Category:Topic Page]] |
Latest revision as of 13:16, 25 May 2023
3D structures of hypoxia-inducible factor3D structures of hypoxia-inducible factor
Updated on 25-May-2023
- HIF-1β or aryl hydrocarbon receptor nuclear translocator (ARNT); C-terminal PAS 345-470
- 2b02, 4eq1 – hARNT PAS-B
- 1x0o, 2hv1, 2k7s – hARNT C-terminal PAS - NMR
- 5ufp – hARNT C-terminal PAS + HIF-2 peptide
- 4pky – hARNT C-terminal PAS + HIF-2 peptide + ARNT-interacting protein
- 4lpz – hARNT C-terminal PAS + coactivator
- 4gs9 – hARNT C-terminal PAS (mutant) + HIF-2 peptide
- 5tbm – hARNT C-terminal PAS + EPAS-1
- 5v0l – hARNT 70-345 + mAHR + DNA
- 4zp4, 4zpk – mARNT + mHIF-2 - mouse
- 7w80 – mARNT + mHIF-2 + drug
- 5nj8 – mARNT 85-345 + AHR + DNA
- 7vni – mARNT 85-345 + DmAHR
- 7v7l, 7v7w – mARNT + mHIF-3
- 5sy5 – mARNT + NPAS1
- 5sy7 – mARNT + NPAS3 + DNA
- 7xhv, 7xi4 – mARNT + NPAS4 + DNA
- 2b02, 4eq1 – hARNT PAS-B
- HIF-2α or endothelial PAS domain-containing protein
- 1p97 – hHIF-2 C-terminal PAS - NMR
- 5kiz – hHIF-2 PAS-B – NMR
- 3f1n, 3f1o, 3h7w, 3h82, 4ghi, 3f1p, 6d0c – hHIF-2 PAS-B (mutant) + ARNT
- 6czw, 6d09, 6d0b, 6x21, 6x28, 6x2h, 6x37, 6x3d – hHIF-2 PAS-B (mutant) + ARNT + inhibitor
- 2a24 – hHIF-2 PAS-B (mutant) + ARNT C-terminal PAS - NMR
- 6bvb – hHIF-2 + elongin B + elongin C + pVHL
- 6e3s – mHIF-2 (mutant) + ARNT
- 4zph – mHIF-2 + ARNT + proflavin
- 4zqd, 6e3t – mHIF-2 + ARNT + inhibitor
- 6e3u – mHIF-2 (mutant) + ARNT + agonist
- 1p97 – hHIF-2 C-terminal PAS - NMR
- HIF-3
- 4wn5 – hHIF-3 C-terminal PAS-B
- 4wn5 – hHIF-3 C-terminal PAS-B